Characterization of angiotensin-converting enzymes 1 and 2 in the soleus and plantaris muscles of rats

Brazilian Journal of Medical and Biological Research

Volumn 43, Issue 9, 2010, Pages 837-842

  Fernandes, T ^a   Hashimoto, N Y ^a   Oliveira, E M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Ace1; Ace2; Rat skeletal muscle; Renin angiotensin system

Indexed keywords

ANGIOTENSIN II; BRADYKININ; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYLCARBOXYPEPTIDASE 1; DIPEPTIDYLCARBOXYPEPTIDASE 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DECAPITATION; ENZYME ACTIVITY; ENZYME ANALYSIS; FEMALE; FLUOROMETRY; GLYCOLYSIS; MUSCLE TISSUE; NONHUMAN; PHENOTYPE; PLANTARIS MUSCLE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SOLEUS MUSCLE; WESTERN BLOTTING;

RATTUS; RATTUS NORVEGICUS;

EID: 77957084109     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2010007500088     Document Type: Article

References (20)

1. Griendling KK, Murphy TJ, Alexander RW. Molecular biology of the renin-angiotensin system. Circulation 1993; 87: 1816-1828.
2. Phillips MI, de Oliveira EM. Brain renin angiotensin in disease. J Mol Med 2008; 86: 715-722.
3. Jones A, Woods DR. Skeletal muscle RAS and exercise performance. Int J Biochem Cell Biol 2003; 35: 855-866.
4. Reneland R, Lithell H. Angiotensin-converting enzyme in human skeletal muscle. A simple in vitro assay of activity in needle biopsy specimens. Scand J Clin Lab Invest 1994; 54: 105-111.
5. Ward PE, Russell JS, Vaghy PL. Angiotensin and bradyki-nin metabolism by peptidases identifed in skeletal muscle. Peptides 1995; 16: 1073-1078.
6. Agoudemos MM, Greene AS. Localization of the renin-angiotensin system components to the skeletal muscle microcirculation. Microcirculation 2005; 12: 627-636.
7. Zoll J, Monassier L, Garnier A, N'Guessan B, Mettauer B, Veksler V, et al. ACE inhibition prevents myocardial infarction-induced skeletal muscle mitochondrial dysfunction. J Appl Physiol 2006; 101: 385-391.
8. Fabre JE, Rivard A, Magner M, Silver M, Isner JM. Tissue inhibition of angiotensin-converting enzyme activity stimulates angiogenesis in vivo. Circulation 1999; 99: 3043-3049.
9. Hruskovicova H, Dzurenkova D, Selingerova M, Bohus B, Timkanicova B, Kovacs L. The angiotensin converting enzyme I/D polymorphism in long distance runners. J Sports Med Phys Fitness 2006; 46: 509-513.
10. Williams AG, Day SH, Folland JP, Gohlke P, Dhamrait S, Montgomery HE. Circulating angiotensin converting enzyme activity is correlated with muscle strength. Med Sci Sports Exerc 2005; 37: 944-948.
11. Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 2000; 275: 33238-33243.
12. Ferrario CM. Angiotensin-converting enzyme 2 and angio-tensin-(1-7): an evolving story in cardiovascular regulation. Hypertension 2006; 47: 515-521.
13. Crackower MA, Sarao R, Oudit GY, Yagil C, Kozieradzki I, Scanga SE, et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 2002; 417: 822-828.
14. Alves MF, Araujo MC, Juliano MA, Oliveira EM, Krieger JE, Casarini DE, et al. A continuous fuorescent assay for the determination of plasma and tissue angiotensin I-converting enzyme activity. Braz J Med Biol Res 2005; 38: 861-868.
15. Sanders PM, Russell ST, Tisdale MJ. Angiotensin II directly induces muscle protein catabolism through the ubiquitin-proteasome proteolytic pathway and may play a role in cancer cachexia. Br J Cancer 2005; 93: 425-434.
16. Gordon SE, Davis BS, Carlson CJ, Booth FW. ANG II is required for optimal overload-induced skeletal muscle hypertrophy. Am J Physiol Endocrinol Metab 2001; 280: E150-E159.
17. McBride TA. AT1 receptors are necessary for eccentric training-induced hypertrophy and strength gains in rat skeletal muscle. Exp Physiol 2006; 91: 413-421.
18. Ferrario CM, Jessup J, Chappell MC, Averill DB, Brosni-han KB, Tallant EA, et al. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation 2005; 111: 2605-2610.
19. Grobe JL, Mecca AP, Lingis M, Shenoy V, Bolton TA, Macha-do JM, et al. Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7). Am J Physiol Heart Circ Physiol 2007; 292: H736-H742.
20. Der Sarkissian S, Grobe JL, Yuan L, Narielwala DR, Walter GA, Katovich MJ, et al. Cardiac overexpression of angiotensin converting enzyme 2 protects the heart from ischemia-induced pathophysiology. Hypertension 2008; 51: 712-718.